Health Care • Medical/Dental Instruments
$123.37 ▼ -4.43
(-3.47%)
MKT CAP: $4.07B • VOL: 533.5K
52W L $101 52W H $192
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$104
MEDIAN
$138
MEAN
$141
HIGH
$168
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE IRTC TAPE
IRTC // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $149.28 | $141.88 | 2025-02-14 | $112.27 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $155.45 | $145.58 | 2025-02-06 | $115.97 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $140.64 | $135.71 | 2025-01-29 | $118.44 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $125.84 | — | 2025-01-17 | $120.90 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $108.57 | $117.20 | 2025-01-09 | $109.80 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $146.81 | $128.30 | 2024-12-18 | $107.33 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $119.67 | $124.60 | 2024-12-04 | $114.73 | -4.3% | 48% | C |